Daily as of 2 Nov 16:00 ET
- Price
- above both $148.36 vs 50 $146.78 / 200 $126.89
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 30 Oct 2025 · projected 19 bars out · tested 6 bars
MRK | Merck & Co.NYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history
$148.36
-$1.16 (-0.78%)
Merck & Co. (MRK) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat above the 200 on the daily since Oct 2025, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits above the 50 and the 200; on the 4-hour it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $149.52 vs 50 $123.38 / 200 $109.51
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 20 Jul 2026 · projected 26 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- between the two $144.74 vs 50 $144.96 / 200 $137.50
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 12 Jun 2026 bar 2 · projected 17 bars out · tested 1 bar
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| week of 20 Jul 2026 | 🟨Golden steep | weekly | 26 bars out | Not tested |
| 12 Jun 2026 | 🟨Golden | 4-hour | 17 bars out | 1 bar cross test |
| 13 May 2026 | 💀Death | 4-hour | 27 bars out | 3 bar cross test |
| 30 Oct 2025 | 🟨Golden moderate | daily | 19 bars out | 6 bar cross test |
| 5 Aug 2025 | 🟨Golden | 4-hour | 15 bars out | — |
About MRK
ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$1.3B
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandmega